EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol Phase 3 Study Results in Systemic Lupus Erythematosus
Topline Results from Phase 2 CELIA Study of Diranersen : First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer's Disease
Biogen to Acquire Apellis, Enhancing the Company's Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
LaFleur Minerals Acquires Additional Mineral Claims to Expand Its McKenzie East Gold Project in Quebec's Val-d'Or Mining District
Metalsource Mining Intersects 434 g/t AgEq Over 10.64 Metres at Silver Hill, Including 2.1kg/t AgEq, While Continuing to Expand Mineralization Along Strike and at Depth
Fathom Announces Assays from Metasedimentary Hosted Nickel-Copper-Cobalt Mineralization at the Gochager Lake Project
Terra Clean Energy Corp. Files NI 43-101 Technical Report For the Marysvale Uranium Mines Project, Utah
CHARBONE decroche un contrat d'approvisionnement en hydrogene a long terme avec Hone Inc. pour soutenir les solutions energetiques propres pour l'industrie du divertissement
